PGR and colonic neoplasm: Some Bi(III) complexes from different dithiocarbamate ligands (N,N-dialkyldithiocarbamates and N-alkyl-N-phenyldithiocarbamates) were synthesised and screened against an array of human cell lines including A498, renal cancer; MCF-7, oestrogen receptor (ER)+/progesterone receptor (PgR)+ breast cancer; EVSA-T, oestrogen receptor (ER)-/progesterone receptor (PgR)—breast cancer; H226, non-small cell lung cancer; IGROV, ovarian cancer; M19 MEL, melanoma; and WIDR, colon cancer by Li et al. [84].